Are JAKis more effective among elderly patients with RA, smokers and those with higher cardiovascular risk? A comparative effectiveness study of b/tsDMARDs in Sweden

Are JAKis more effective among elderly patients with RA, smokers and those with higher cardiovascular risk? A comparative effectiveness study of b/tsDMARDs in Sweden

Objectives To investigate whether the relative effectiveness of janus kinase inhibitors (JAKis) versus tumour necrosis factor inhibitors (TNFi) or other biological disease-modifying antirheumatic drugs in rheumatoid arthritis differ by the presence or absence of risk factors for cardiovascular (CV)...

Full description

Bibliographic Details
Main Authors:	Johan Askling, Katerina Chatzidionysiou, Carl Turesson, Elisabet Lindqvist, Thomas Frisell, Daniela Di Giuseppe, Helena Forsblad-d'Elia, Bénédicte Delcoigne, Hannah Bower, Ann Knight
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2023-10-01
Series:	RMD Open
Online Access:	https://rmdopen.bmj.com/content/9/4/e003648.full

Similar Items

Use of a bDMARD or tsDMARD for the management of inflammatory arthritis under checkpoint inhibitors: an observational study
by: Marie Kostine, et al.
Published: (2022-10-01)

Cost-utility analysis of biologic disease-modifying antirheumatic drugs (bDMARDs), targeted synthetic DMARDs (tsDMARDs) and biosimilar DMARDs (bsDMARDs) combined with methotrexate for Thai rheumatoid arthritis patients with high disease activity
by: Juthamas Prawjaeng, et al.
Published: (2023-05-01)

Comparative cardiovascular safety with janus kinase inhibitors and biological disease-modifying antirheumatic drugs as used in clinical practice: an observational cohort study from Sweden in patients with rheumatoid arthritis
by: Johan Askling, et al.
Published: (2023-11-01)

The accelerated waning of immunity and reduced effect of booster in patients treated with bDMARD and tsDMARD after SARS-CoV-2 mRNA vaccination
by: Selma Tobudic, et al.
Published: (2023-02-01)

Patient and physician assessment in difficult-to-treat rheumatoid arthritis: patterns of subjective perception at early stages of b/tsDMARD treatment
by: Alejandro Balsa, et al.
Published: (2023-07-01)

The Impact of b/tsDMARD Dose Reduction on Chronic Hepatitis B in Rheumatoid Arthritis Patients: A Two-Center Long-Term Safety Analysis
by: Der-Yuan Chen, et al.
Published: (2022-12-01)

Development of a web-based decision aid for initiating biological or targeted synthetic disease-modifying antirheumatic drugs (b/tsDMARDs) in axial spondyloarthritis
by: Astrid van Tubergen, et al.
Published: (2023-04-01)

Does persistence to methotrexate treatment in early rheumatoid arthritis have a familial component?
by: Anton Öberg Sysojev, et al.
Published: (2022-08-01)

Risk of Psychiatric Disorders in Juvenile Idiopathic Arthritis: Population‐ and Sibling‐Controlled Cohort and Cross‐Sectional Analyses
by: Bénédicte Delcoigne, et al.
Published: (2023-05-01)

"Wspólnotowy", czyli jaki? – rozważania leksykograficzne
by: Jolanta Migdał, et al.
Published: (2023-12-01)

STANLEY L. JAKI, Newman’s Challenge
by: José Joaquín Alemany SJ
Published: (2019-02-01)

Occurrence and relative risks for non-vertebral fractures in patients with ankylosing spondylitis compared with the general population: a register-based study from Sweden
by: Johan Askling, et al.
Published: (2023-02-01)

Comorbidities and chance of remission in patients with early rheumatoid arthritis receiving methotrexate as first-line therapy: a Swedish observational nationwide study
by: Johan Askling, et al.
Published: (2023-10-01)

Comorbidities and treatment patterns in early rheumatoid arthritis: a nationwide Swedish study
by: Johan Askling, et al.
Published: (2022-12-01)

REFERENDUM LOKALNE W POLSCE – ALE JAKIE?
by: Paweł CIEŚLIŃSKI
Published: (2016-09-01)

„Takie samo miejsce” dla „orłów i komarów Parnasu”, czyli jaki dramat (i jaki teatr dla tego dramatu) zaprojektowali nasi oświeceni
by: Dobrochna Ratajczakowa
Published: (2017-10-01)

Inadequate Dietary Nutrient Intake in Patients With Rheumatoid Arthritis in Southwestern Sweden: A Cross-Sectional Study
by: Anna Turesson Wadell, et al.
Published: (2022-06-01)

Impact of multimorbidity on the first ts/bDMARD effectiveness and retention rate after two years of follow-up in patients with rheumatoid arthritis from the BIOBADASER registry
by: Jerusalem Calvo-Gutiérrez, et al.
Published: (2024-02-01)

A SURVEY OF DMARD PREFERENCES OF UK RHEUMATOLOGISTS
by: Douglas, K, et al.
Published: (2003)

The efficacy of tofacitinib combined with bDMARDs in the treatment of ankylosing spondylitis patients with inadequate response to bDMARDs: a retrospective study
by: Jie Chang, et al.
Published: (2024-01-01)

Book review of: Jáki, E., & Huszák, L. (2022). Quo vadis entrepreneurship education?
by: Endre Mihály Molnár
Published: (2022-12-01)

In Patients with Early Peripheral Psoriatic Arthritis Baseline C-Reactive Protein, Pain and Ultrasound-Detected Synovitis Predict Subsequent Treatment with ts/bDMARDs. A Retrospective Analysis
by: Garifallia Sakellariou, et al.
Published: (2021-06-01)

Ixekizumab efficacy and safety with and without concomitant conventional disease-modifying antirheumatic drugs (cDMARDs) in biologic DMARD (bDMARD)-naïve patients with active psoriatic arthritis (PsA): results from SPIRIT-P1
by: Coates, L, et al.
Published: (2017)

Myocardial infarction in rheumatoid arthritis: The effects of DMARDs and prednisolone
by: Edwards, C, et al.
Published: (2008)

DMARDs–Gut Microbiota Feedback: Implications in the Response to Therapy
by: Oscar Zaragoza-García, et al.
Published: (2020-10-01)

Patients with radiographic axial spondylarthritis have an impaired dietary intake—a cross-sectional study with matched controls from northern Sweden
by: Erik Hulander, et al.
Published: (2023-08-01)

MOMENTUM: momelotinib vs danazol in patients with myelofibrosis previously treated with JAKi who are symptomatic and anemic
by: Verstovsek, S, et al.
Published: (2021)

„Czy to faktycznie jakiś tam ma sens?”. Współczesne doświadczenia (nie)religijne młodego pokolenia
by: Kaja Kaźmierska
Published: (2024-01-01)

Measuring the effect of Users' Privacy Concerns on the Use of Jakarta Smart City Mobile Application (JAKI)
by: Arif Wahyudi, et al.
Published: (2022-12-01)

Jaki jest porządny człowiek? O wybranych użyciach przymiotnika porządny we współczesnej polszczyźnie
by: Karolina Lisczyk
Published: (2022-12-01)

Jaki jest piesek? Śliczny.  O recepcji twórczości Wisławy Szymborskiej  wśród japońskich studentów
by: Barbara Morcinek
Published: (2020-12-01)

Effect of concomitant conventional disease-modifying antirheumatic drugs (cDMARDs) on the efficacy and safety of ixekizumab in biologic dmard-naive patients with active psoriatic arthritis
by: Coates, LC, et al.
Published: (2016)

Risk of lung cancer in rheumatoid arthritis and in relation to autoantibody positivity and smoking
by: Johan Askling, et al.
Published: (2022-10-01)

The serological immunogenicity of the third and fourth doses of COVID-19 vaccine in patients with inflammatory rheumatic diseases on different biologic or targeted DMARDs: a Swedish nationwide study (COVID-19-REUMA)
by: Martina Frodlund, et al.
Published: (2024-04-01)

A survey of British rheumatologists' DMARD preferences for rheumatoid arthritis.
by: Jobanputra, P, et al.
Published: (2004)

Combination therapy with DMARDs and biological agents in collagen-induced arthritis.
by: Williams, R, et al.
Published: (1999)

To pewnie jakiś rablador pisał — o funkcjach odstępstw od normy językowej w dyskursie internetowym
by: Katarzyna Jachimowska
Published: (2022-12-01)

Jaki kolor ma wiedźma? Wizerunki kolorystyczne czarownic w filmach animowanych wytwórni Walta Disneya
by: Alicja Baczyńska-Hryhorowicz
Published: (2022-12-01)

Teacher shortage in Sweden: time to take action?
by: Marcia Håkansson Lindqvist, et al.
Published: (2022-11-01)

Factors influencing choice of b/ts DMARDs in managing inflammatory arthritis from a patient perspective: a systematic review of global evidence and a patient-based survey from Hong Kong
by: Dexing Zhang, et al.
Published: (2023-10-01)